A business in context
STE research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-15 | Zangerle John Adam | S · Sale | Ordinary Shares | 1419.0 | 209.28 |
| 2026-06-05 | Carestio Daniel A | S · Sale | Ordinary Shares | 1374.0 | 212.0 |
| 2026-06-04 | Zangerle John Adam | F · Tax / exercise payment | Ordinary Shares | 401.0 | 212.24 |
| 2026-06-04 | Tamaro Renato | F · Tax / exercise payment | Ordinary Shares | 65.0 | 212.24 |
| 2026-06-04 | Madsen Julia | F · Tax / exercise payment | Ordinary Shares | 195.0 | 212.24 |
| 2026-06-04 | Kohler Kenneth E | F · Tax / exercise payment | Ordinary Shares | 150.0 | 212.24 |
| 2026-06-04 | Fraser Mary Clare | F · Tax / exercise payment | Ordinary Shares | 600.0 | 212.24 |
| 2026-06-04 | Carestio Daniel A | S · Sale | Ordinary Shares | 3054.0 | 214.64 |
| 2026-06-04 | Carestio Daniel A | F · Tax / exercise payment | Ordinary Shares | 1889.0 | 212.24 |
| 2026-06-04 | Burton Karen L | F · Tax / exercise payment | Ordinary Shares | 90.0 | 212.24 |
| 2026-06-03 | Zangerle John Adam | F · Tax / exercise payment | Ordinary Shares | 365.0 | 210.19 |
| 2026-06-03 | Tamaro Renato | F · Tax / exercise payment | Ordinary Shares | 64.0 | 210.19 |
| 2026-06-03 | Madsen Julia | F · Tax / exercise payment | Ordinary Shares | 239.0 | 210.19 |
| 2026-06-03 | Kohler Kenneth E | F · Tax / exercise payment | Ordinary Shares | 184.0 | 210.19 |
| 2026-06-03 | Fraser Mary Clare | F · Tax / exercise payment | Ordinary Shares | 311.0 | 210.19 |
| 2026-06-03 | Carestio Daniel A | F · Tax / exercise payment | Ordinary Shares | 2619.0 | 210.19 |
| 2026-06-03 | Burton Karen L | F · Tax / exercise payment | Ordinary Shares | 190.0 | 210.19 |
| 2026-06-02 | Zangerle John Adam | A · Grant / award | Ordinary Shares | 4359.0 | 0.0 |
| 2026-06-02 | Zangerle John Adam | F · Tax / exercise payment | Ordinary Shares | 247.0 | 209.76 |
| 2026-06-02 | Zangerle John Adam | A · Grant / award | Employee Stock Option (right to buy) | 15200.0 | 0.0 |
| 2026-06-02 | Tamaro Renato | F · Tax / exercise payment | Ordinary Shares | 41.0 | 209.76 |
| 2026-06-02 | Tamaro Renato | A · Grant / award | Ordinary Shares | 750.0 | 0.0 |
| 2026-06-02 | Tamaro Renato | A · Grant / award | Employee Stock Option (right to buy) | 2620.0 | 0.0 |
| 2026-06-02 | McGowan Lindsey | F · Tax / exercise payment | Ordinary Shares | 329.0 | 209.76 |
| 2026-06-02 | McGowan Lindsey | A · Grant / award | Ordinary Shares | 1155.0 | 0.0 |
| 2026-06-02 | McGowan Lindsey | A · Grant / award | Employee Stock Option (right to buy) | 4036.0 | 0.0 |
| 2026-06-02 | Majors Cary L | F · Tax / exercise payment | Ordinary Shares | 67.0 | 209.76 |
| 2026-06-02 | Majors Cary L | A · Grant / award | Ordinary Shares | 4746.0 | 0.0 |
| 2026-06-02 | Majors Cary L | A · Grant / award | Employee Stock Option (right to buy) | 16548.0 | 0.0 |
| 2026-06-02 | Madsen Julia | A · Grant / award | Ordinary Shares | 2316.0 | 0.0 |
| 2026-06-02 | Madsen Julia | F · Tax / exercise payment | Ordinary Shares | 127.0 | 209.76 |
| 2026-06-02 | Madsen Julia | A · Grant / award | Employee Stock Option (right to buy) | 8080.0 | 0.0 |
| 2026-06-02 | Kohler Kenneth E | F · Tax / exercise payment | Ordinary Shares | 66.0 | 209.76 |
| 2026-06-02 | Kohler Kenneth E | A · Grant / award | Ordinary Shares | 2199.0 | 0.0 |
| 2026-06-02 | Kohler Kenneth E | A · Grant / award | Employee Stock Option (right to buy) | 7668.0 | 0.0 |
| 2026-06-02 | Fraser Mary Clare | F · Tax / exercise payment | Ordinary Shares | 591.0 | 209.76 |
| 2026-06-02 | Fraser Mary Clare | A · Grant / award | Ordinary Shares | 3009.0 | 0.0 |
| 2026-06-02 | Fraser Mary Clare | A · Grant / award | Employee Stock Option (right to buy) | 10492.0 | 0.0 |
| 2026-06-02 | Carestio Daniel A | F · Tax / exercise payment | Ordinary Shares | 995.0 | 209.76 |
| 2026-06-02 | Carestio Daniel A | A · Grant / award | Ordinary Shares | 23736.0 | 0.0 |
| 2026-06-02 | Carestio Daniel A | A · Grant / award | Employee Stock Option (right to buy) | 82740.0 | 0.0 |
| 2026-06-02 | Burton Karen L | A · Grant / award | Ordinary Shares | 5325.0 | 0.0 |
| 2026-06-02 | Burton Karen L | M · Exercise / conversion | Ordinary Shares | 66.0 | 209.76 |
| 2026-06-02 | Burton Karen L | A · Grant / award | Employee Stock Option (right to buy) | 18564.0 | 0.0 |
| 2026-06-02 | Boulud Pierre | A · Grant / award | Career Restricted Stock Units | 367.0 | 0.0 |
| 2026-06-02 | Breeden Richard C | M · Exercise / conversion | Ordinary Shares | 3781.0 | 71.4 |
| 2026-06-02 | Breeden Richard C | S · Sale | Ordinary Shares | 1481.0 | 209.51 |
| 2026-06-02 | Breeden Richard C | M · Exercise / conversion | Employee Stock Option (right to buy) | 3781.0 | 0.0 |
| 2026-06-01 | Zangerle John Adam | F · Tax / exercise payment | Ordinary Shares | 337.0 | 0.0 |
| 2026-06-01 | Tamaro Renato | F · Tax / exercise payment | Ordinary Shares | 81.0 | 0.0 |
Identity & relationships
SEC issuer · 0001757898STERIS plc
Steris (United Kingdom)Steris (France)
- Legal Entity Identifier
- 549300AFNA4MU5267137
- GLEIF legal name
- STERIS CORPORATION
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-04-06T09:40:14Z
Search names and former names
View Wikidata identity and references ↗
- STERIS · alias · wikidata
- Steris Corporation · alias · wikidata
- Steris (United Kingdom) · subsidiary · wikidata
- Steris (France) · subsidiary · wikidata
- STERIS Ltd · former SEC name · 2018-11-06 to 2019-03-28
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2025-03-31 | $5.46B | $5.77B |
| 2024-03-31 | $5.14B | $5.59B |
| 2023-03-31 | $4.54B | $5.10B |
| 2022-03-31 | $4.22B | $5.11B |
| 2021-03-31 | $3.11B | $3.99B |
| 2020-03-31 | $3.03B | $3.94B |
| 2019-03-31 | $2.78B | $3.68B |
| 2018-03-31 | $2.62B | $3.55B |